Cargando…
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histones and have attracted attention as potential targets for cancer therapy. Several small molecule inhibitors have been developed to target HDACs; however, clinical trials of pan-HDAC inhibitors have found these types of inhi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709567/ https://www.ncbi.nlm.nih.gov/pubmed/33281975 http://dx.doi.org/10.3892/ol.2020.12315 |